MedTrace Logo

Effects of the General Practitioners and Diabetes Specialists Co-management Model for Patients With Type 2 Diabetes

NCT05556161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 609

Last updated 2025-04-30

No results posted yet for this study

Summary

This is a prospective, randomized, parallel, multicenter controlled study to evaluate the effectiveness of the general practitioners and diabetes specialists co-management model for type 2 diabetes. Patients with type 2 diabetes will be randomized to participate in the community general practitioners and diabetes specialists management or serve as controls continuing with routine primary health care. The primary outcome is to observe the HbA1c change.

Conditions

  • Type2diabetes

Interventions

BEHAVIORAL

General Practitioners and Diabetes Specialists Co-management

Self-monitoring of blood glucose: Participants will monitor blood glucose with a a free intelligent home blood glucose meter. Then, the intelligent blood glucose meter will upload data to the platform. Glycosylated hemoglobin check: Cooperative General Practitioner-Specialist Management: Based on the remote monitoring of blood glucose, general practitioners and specialists will jointly carry out management measures including health education, medication adjustment, outpatient consultation, referral, case discussion, etc. for participants.

Sponsors & Collaborators

  • Baoan Central Hospital of Shenzhen

    collaborator UNKNOWN

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Xiaoxv Yin · Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2023-05-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05556161 on ClinicalTrials.gov